Reshma Shringarpure
- Molecular Biology top 2%
- Epidemiology top 2%
- Oncology top 2%
- Hematology top 1%
- Cell Biology top 2%
- Co-authors
- Kelvin J.A. DaviesTilman GruneTeru HideshimaKenneth C. AndersonDharminder ChauhanNicholas MitsiadesConstantine S. MitsiadesNikhil C. Munshi
- Topics
- Liver Disease Diagnosis and Treatment (28 papers)Multiple Myeloma Research and Treatments (17 papers)Ubiquitin and proteasome pathways (10 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Reshma Shringarpure
69 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 2.9k
- Epidemiology 1.2k
- Oncology 1.0k
- Hematology 1.0k
- Cell Biology 671
Countries citing papers authored by Reshma Shringarpure
This map shows the geographic impact of Reshma Shringarpure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshma Shringarpure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshma Shringarpure more than expected).
Fields of papers citing papers by Reshma Shringarpure
This network shows the impact of papers produced by Reshma Shringarpure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshma Shringarpure. The network helps show where Reshma Shringarpure may publish in the future.
Co-authorship network of co-authors of Reshma Shringarpure
This figure shows the co-authorship network connecting the top 25 collaborators of Reshma Shringarpure. A scholar is included among the top collaborators of Reshma Shringarpure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reshma Shringarpure. Reshma Shringarpure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 37 | |
| 3 | 16 | |
| 4 | Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trialbreakdown → | 146 |
| 5 | 72 | |
| 6 | 122 | |
| 7 | 9 | |
| 8 | 106 | |
| 9 | 6 | |
| 10 | 55 | |
| 11 | 74 | |
| 12 | 470 | |
| 13 | Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of b1-integrin and phosphatidylinositol 3-kinase/AKT signaling beta. | 33 |
| 14 | Gene expression analysis of tumor cells sensitive and resistant to PS-341 (Bortezomib) treatment: Clinical implications. | 1 |
| 15 | 29 | |
| 16 | Thalidomide analogue IMiD3 provides T cell co-stimulation through B7-CD28 pathway. | 1 |
| 17 | 186 | |
| 18 | 358 | |
| 19 | 173 | |
| 20 | 121 |
About Reshma Shringarpure
Reshma Shringarpure is a scholar working on Hepatology, Hematology and Epidemiology, having authored 72 papers that have together received 4.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (28 papers), Multiple Myeloma Research and Treatments (17 papers) and Ubiquitin and proteasome pathways (10 papers). The work is most often cited by research in Hematology (1.0k citations), Hepatology (356 citations) and Molecular Biology (2.9k citations). Reshma Shringarpure has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Kelvin J.A. Davies, Tilman Grune, Teru Hideshima, Kenneth C. Anderson, Dharminder Chauhan, Nicholas Mitsiades, Constantine S. Mitsiades, Nikhil C. Munshi, Jana Mehlhase and Klaus Podar. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.